Menu
Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 8
Non-melanoma skin cancer in renal transplant recipients: a study in a Brazilian reference center
Authors Gonçalves C, Trope B, Ramos-e-Silva M
Received 1 December 2014
Accepted for publication 18 February 2015
Published 7 July 2015 Volume 2015:8 Pages 339—344
DOI https://doi.org/10.2147/CCID.S78456
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 3
Editor who approved publication: Dr Jeffrey Weinberg
Carolina Pereira Gonçalves, Beatriz Moritz Trope, Marcia Ramos-e-Silva
Sector of Dermatology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
Background: Non-melanoma skin cancer (NMSC) after kidney transplantation is common and can result in significant morbidity and mortality. Their incidence and risk factors in renal transplant recipients (RTRs) vary depending on geographic location and there is a scarcity of literature describing the features of NMSC in Brazil.
Methods: NMSC data were retrospectively reviewed in charts of RTRs at the Clementino Fraga Filho University Hospital from January 2004 to December 2005, with the objectives of: 1) evaluating the occurrence of NMSC in RTRs transplanted between 2004 and 2005 at a reference center in Brazil; 2) verifying the frequency of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) in these patients according to sex, race, age, and tumor site; and 3) determining the time between transplantation and neoplasia.
Results: We found 202 RTRs, with 165 suitable for the study. There were 19 NMSC in eleven patients (6.67%), at a mean time of 37.7 months after transplantation. The mean follow-up time was 72.7 months. The ratio of SCC:BCC was 1.1:1. White race and age ≥40 years were associated with a higher incidence of NMSC and they appeared predominantly in sun-exposed sites.
Conclusion: Regular dermatological follow-up of RTRs can help to make earlier diagnoses, resulting in better quality of life and lower morbidity and mortality.
Keywords: squamous cell carcinoma, basal cell carcinoma, Brazil
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.